KAKazuo Abe

Kazuo Abe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kazuo Abe has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A New Case With Cortical Malformation Caused by Biallelic Variants in LAMC3

    by Kazuo Abe, Kumiko Ando, Mitsuhiro Kato, Hirotomo Saitsu, Mitsuko Nakashima, Shintaro Aoki, Takashi Kimura

    Objective In this study, we report the case of a 24-year-old man with intellectual disability and childhood-onset seizures. This patient had newly identified biallelic variants in the laminin subunit gamma 3 (LAMC3) gene with unreported cortical malformation. Methods Exome sequencing. Results Genetic analyses revealed new biallelic variants in the LAMC3 gene. An MRI examination of the brain revealed cortical malformations predominantly in the temporal lobes and mildly in the occipital, frontal, and parietal lobes. In addition, our patient also exhibited mild midline malformation in the ventral pons, which is unique to LAMC3 variants. Discussion Patients with LAMC3 variants have been reported to exhibit cortical malformation predominantly in the occipital lobes, but this patient exhibited cortical malformation predominantly in the temporal lobes and mildly in the occipital, frontal, and parietal lobes. In addition, this patient also exhibited mild midline malformation in the ventral pons. These unique findings cast new light on the role of LAMC3 in brain development.


  • Open Access

    Experience with the Rehabilitation of Patients with Parkinson's Disease Using Levodopa-Carbidopa Intestinal Gel(LCIG)Treatment for Their Return to Work

    by Goichi Hashida, Naoki Kato, Kuni Konaka, Kazuo Abe

    Patients with Parkinson's disease (PD) experience difficulties with activities of daily living (ADLs) at workplace and in their social life depending on the extent of disease progression. Because of their disabilities, patients with PD are forced into early retirement compared to other people of their age group. We present our experience with the rehabilitation of three patients with PD using levodopa-carbidopa intestinal gel (LCIG) treatment for their return to work. The rehabilitation program comprised the following three modules:1) evaluating the patients' ability to walk indoor for a short time;2) assessing their standing and sitting positions to enable them to more easily handle a device;and 3) improving their upper limb function, including skilled movements, for operating a device in emergency. Finally, all three patients exhibited improvements in the Timed Up and Go test results and device operation. Two of the patients returned to their former workplace within 10 months of LCIG treatment initiation and the remaining patient found new employment 1 year after treatment commencement. In conclusion, establishing a rational support system that involves rehabilitation programs and information sharing across multiple occupations is essential for the return to work of patients with PD receiving LCIG treatment.

  • Open Access

    Patient with Niemann-Pick disease type C: over 20 years' follow-up

    by Kazuo Abe, Norio Sakai

    We report a 37-year-old woman with Niemann-Pick disease type C (NPC) 1. At the age of 8 years, she presented slow running followed by both fingers dystonia at the age of 10 years. At the age of 16 years, she developed declined scholastic achievement. On her first visit at the age of 17 years, she showed dystonia, ataxic gait and vertical supranuclear gaze palsy. We suspected it was NPC. She presented atrophies in the frontal lobes, brainstem and cerebellum in a brain MRI. She presented hepatomegalies and splenomegalies in an abdominal CT. At the age of 26 years, she undertook perpetually tracheal fistula because of recurrent aspiration pneumonia. Diagnosis of NPC1 was made by filipin staining and existence of foamy cells in the bone marrow and NPC1 gene analysis. We obtained informed consent of genetic analysis. Miglustat therapy was started at the age of 32 years. Improvements in swallowing capacity and in muscle tonus were seen.


  • Open Access

    Over 10 years MRI observation of a patient with neuronal intranuclear inclusion disease

    by Kazuo Abe, Masashi Fujita

    We present a sporadic neuronal intranuclear inclusion disease (NIID) patient with neuropathy followed by cognitive dysfunction along with brain MRIs findings of leucoencephalopathy. Her cognitive impairment gradually progressed along with abnormal intensity lesions in diffusion-weighted images. This pathological and clinical deterioration resemble pathological process in prion diseases.


  • Open Access

    A Spinal Dural Arteriovenous Fistula with Lower Motor Neuron Involvement

    by Makoto Kinoshita, Masayuki Moriya, Takashi Kimura, Yoichi Yamamoto, Kazuo Abe, Katsuhiko Hayashi, Saburo Sakoda

    Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

  • The fluid-attenuated inversion-recovery pulse sequence in assessment of central nervous system involvement in myotonic dystrophy

    by K. Abe, H. Fujimura, F. Soga

    We compared the fluid-attenuated inversion recovery (FLAIR) sequence with conventional spin-echo (SE) imaging for detection of involvement of the central nervous system in five patients with myotonic dystrophy (MD). The diagnosis was made based on clinical features and DNA analysis. All patients showed abnormal high-intensity lesions in the white matter on T2-weighted images, although these were more clearly visible using FLAIR.


  • Isoflurane in the management of status epilepticus after surgery for lesion around the motor area

    by T. Sakaki, K. Abe, T. Hoshida, T. Morimoto, S. Tsunoda, K. Okuchi, S. Miyamoto, H. Furuya

    When conventional treatment for status epilepticus fails, general anaesthesia is recommended. We present our experience with isoflurane, an inhalational anaesthetic, in the management of four patients with status epilepticus which occurred soon after surgery for motor area lesion. The seizures were controlled with relatively small concentrations of isoflurane. Hypotension, the only adverse effect of isoflurane, was managed easily with the use of dopamine in physiological saline. Although status epilepticus occurring soon after surgery is transient, it carries a risk of persistent brain damage if active treatment is not instituted promptly. Isoflurane general anaesthesia may be recommended to control it in the intensive neurosurgical care.


  • Open Access

    Spinocerebellar degeneration (SCD): cognitive disturbances

    by N. Hirono, A. Yamadori, M. Kameyama, T. Mezaki, K. Abe

    The performance of 30 patients younger than 65 years with spinocerebellar degeneration (SCD) was compared with control subjects matched for age, sex, and education in standardized neuropsychological tests. SCD patients exhibited abnormalities in WAIS, in the recall test of anterograde verbal memory, in verbal fluency, in visuospatial function and on the depression scale. However, they exhibited no deficit in the recognition test of anterograde verbal memory. No patients showed impaired visual confrontation naming. The pattern of neuropsychological deficits exhibited by the SCD patients closely approximated the profile observed in other types of subcortical dementia. There were no significant differences between the SCD patients with pontine atrophy and those without pontine atrophy in any of the neuropsychological examinations.


  • Open Access

    Immunohistological and Biochemical Detection of Fucosylated Polylactosamine Antigen with Monoclonal Antibody ACFH18 in Gastric Cancer and Normal Gastric Mucosa

    by Taeko Dohi, Kazuo Abe, Saburo Ohshiba, Kenji Yamaguchi, Mieko Oshima

    A mouse monoclonal antibody ACFH18, produced by immunizing with human gastric cell line MKN‐74, recognizes a novel glycolipid antigen, fucosyl‐lactoneodecaosylceramide. In the present study, we investigated the immunohistological localization of this antigen and its biochemical detection in glycolipid fraction in normal and malignant human gastric tissue, compared with other tumor‐associated type‐2 chain glycolipid antigens such as sialyl Lex, sialyl Lex‐i and Ley. Reactivity with ACFH18 was detected immunohistologically in the proliferating zone of normal fundic gland region as well as in 38 of 54 cases of gastric cancer, with preferential binding to undifferentiated type cancer. Glycolipids reacting with ACFH18, especially slow‐migrating glycolipids on thin‐layer chromatography, were accumulated in all of four cancer specimens compared with normal mucosa obtained from the same patients. Many glycolipids with sialyl Lex or sialyl Lex‐i epitope were detected in normal mucosa and almost all of these glycolipids were accumulated in cancer specimens. Sialyl Lex‐i antigen was increased more specifically in cancer than sialyl Lex was. A Ley antigenic glycolipid was considerably decreased in three of four cancer cases and increased in one case. From these results, glycolipid detected by ACFH18 appeared to be a tumor‐associated antigen comparable to sialyl Lex and sialyl Lex‐i antigens, but with a unique character as an undifferentiated‐type tumor‐associated antigen.